Bright Health Group, Inc. (BHG)
NYSE: BHG · IEX Real-Time Price · USD
10.61
+0.02 (0.19%)
At close:
Jun 2, 2023, 4:00 PM
10.40
-0.21 (-1.98%)
After-hours:
Jun 2, 2023, 7:57 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Revenue | 2,412.03 | 1,513.03 | 1,207.32 | 280.67 | 130.63 |
Revenue Growth (YoY) | 59.42% | 25.32% | 330.15% | 114.86% | - |
Cost of Revenue | 2,206.24 | 1,294.16 | 1,047.3 | 224.39 | 96.41 |
Gross Profit | 205.79 | 218.88 | 160.02 | 56.29 | 34.23 |
Selling, General & Admin | 632.03 | 527.45 | 409.33 | 180.49 | 95.84 |
Other Operating Expenses | 196.01 | 35.05 | 8.29 | 1.13 | 1.03 |
Operating Expenses | 828.04 | 562.5 | 417.62 | 181.62 | 96.87 |
Operating Income | -622.25 | -343.63 | -257.6 | -125.34 | -62.64 |
Interest Expense / Income | 12.82 | 7.23 | 0 | 0 | 0 |
Other Expense / Income | 816.8 | 860.53 | - | - | - |
Pretax Income | -1,451.86 | -1,211.38 | -257.6 | -125.34 | -62.64 |
Income Tax | 3.68 | -26.52 | -9.16 | 0 | 0 |
Net Income | -1,455.54 | -1,184.86 | -248.44 | -125.34 | -62.64 |
Preferred Dividends | 39.69 | 0 | 0 | 0 | 0 |
Net Income Common | -1,495.23 | -1,184.86 | -248.44 | -125.34 | -62.64 |
Shares Outstanding (Basic) | 8 | 5 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | - | 5 | 2 | 2 | 2 |
Shares Change | 60.63% | 188.01% | 1.27% | 1.90% | - |
EPS (Basic) | -190.40 | -241.60 | -145.60 | -74.40 | -37.60 |
EPS (Diluted) | -190.40 | -241.60 | -145.60 | -74.40 | -37.60 |
Free Cash Flow Per Share | 26.29 | 10.53 | -37.42 | -5.35 | -16.81 |
Gross Margin | 8.53% | 14.47% | 13.25% | 20.05% | 26.20% |
Operating Margin | -25.80% | -22.71% | -21.34% | -44.66% | -47.95% |
Profit Margin | -61.99% | -78.31% | -20.58% | -44.66% | -47.95% |
Free Cash Flow Margin | 8.58% | 3.41% | -5.28% | -3.21% | -21.23% |
EBITDA | -1,388.47 | -1,168.67 | -249.31 | -124.2 | -61.61 |
EBITDA Margin | -57.56% | -77.24% | -20.65% | -44.25% | -47.16% |
Depreciation & Amortization | 50.58 | 35.48 | 8.29 | 1.13 | 1.03 |
EBIT | -1,439.04 | -1,204.15 | -257.6 | -125.34 | -62.64 |
EBIT Margin | -59.66% | -79.59% | -21.34% | -44.66% | -47.95% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).